The North America Optical Imaging Market would witness market growth of 11.7% CAGR during the forecast period (2022-2028).
Modern cell biology is quickly advancing in preclinical and clinical contexts, with new methods, contrast agents, and equipment arriving virtually daily. Fluorescence microscopy techniques are utilized to improve picture contrast and spatial resolution. Fluorescence lifetime imaging, fluorescence recovery after photobleaching, and fluorescence correlation spectroscopy are just a few of the many fluorescent microscope technologies that are currently available.
Other techniques include stimulated emission depletion, structured illumination, Förster resonance energy transfer, wide-field, laser scanning confocal, 2-photon, scanning disc confocal, and super-resolution. Analytical chemistry, spectroscopy, biosensing, fluorescence-activated cell sorting, DNA detection, flow cytometry, live cell imaging, fluorescent protein labeling, and fluorescence image-guided surgery are among fluorescent microscopy applications.
A 14.6% increase in financing for the health sector is planned in Mexico's 2022 budget. First and second-level treatments for high-specialty illnesses like diabetes, cancer, and heart disease are given priority. Around 25 to 30 percent of Mexico's population is served by private healthcare facilities, whereas public healthcare facilities give 70 to 80 percent of all medical services. This considers how the two systems overlap and the 32 million individuals with private health and accident insurance. With 4,629 hospitals, 194 highly specialized medical facilities, and 3,114 licensed private hospitals, Mexico had 22,831 public healthcare units in 2019. The increasing government funding for the healthcare sector, combined with the rising work to increase the reachability of healthcare, will increase the usage of optical imaging for treatments and diagnosis, thereby driving market growth in the region.
The US market dominated the North America Optical Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $744.2 Million by 2028. The Canada market is poised to grow at a CAGR of 14.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 13.3% during (2022 - 2028).
Based on Product, the market is segmented into Imaging Systems, Illuminating Systems, Camera, Software and Lenses & Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Laboratories and Pharmaceutical & Biotechnology Companies. Based on Technique, the market is segmented into Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging and Photoacoustic Tomography. Based on Application, the market is segmented into Pathological Imaging and Intraoperative Imaging. Based on Therapeutic Area, the market is segmented into Oncology, Ophthalmology, Cardiology, Dermatology, Neurology and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Optical Imaging Market is Projected to reach USD 3.1 Billion by 2028, at a CAGR of 13.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 